These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5072843)

  • 1. [Evaluation of oxytocinasemia borderline values in fetal maturation disorders].
    Bryniak C; Bieniasz A; Bogdanowicz M; Milewicz-Kalista W
    Ginekol Pol; 1972; 43(8):951-5. PubMed ID: 5072843
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxytocinasemia in multiple pregnancy.
    Klimek R; Bryniak C; Kallista-Milewicz W; Milewicz S; Paradysz A
    Acta Genet Med Gemellol (Roma); 1974; 22 suppl():54-6. PubMed ID: 4440427
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of serum cystine aminopeptidase and urinary estrogen excretion as placental function tests.
    Curzen P; Varma R
    Am J Obstet Gynecol; 1973 Apr; 115(7):929-32. PubMed ID: 4695308
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of plasma oxytocinase in the assessment of fetal-placental function.
    Blunt A
    Aust N Z J Obstet Gynaecol; 1971 Feb; 11(1):37-43. PubMed ID: 5281221
    [No Abstract]   [Full Text] [Related]  

  • 5. The oxytocin challenge test, plasma estriol, and human placental lactogen values in high-risk pregnancy.
    Bashore RA; Staisch KJ; Westlake JR
    Trans Pac Coast Obstet Gynecol Soc; 1979; 46():13-9. PubMed ID: 542969
    [No Abstract]   [Full Text] [Related]  

  • 6. How is the baby?: the Apgar score revisited.
    Scanlon JW
    Clin Pediatr (Phila); 1973 Feb; 12(2):61-3. PubMed ID: 4686858
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxytocin challenge test in monitoring high-risk pregnancies.
    Cooper JM; Soffronoff EC; Bolognese RJ
    Obstet Gynecol; 1975 Jan; 45(1):27-33. PubMed ID: 1110815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cystine-amino-peptidase (C.A.P.) and D.B.P. in "at risk" pregnancy with "poor intrauterine fetale growth" (P.I.F.G.) (author's transl)].
    Mansani FE; Condemi V; Verrelli D; Serventi G; Chiavazza F; Ceruti M
    Ateneo Parmense Acta Biomed; 1976; 47(6):647-56. PubMed ID: 1032958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fetal prognosis of amnioscopy with clear amniotic fluid].
    Fernández E; Molina R; Echeverría E; Carmona A; Sepúlveda J
    Rev Chil Obstet Ginecol; 1974; 39(2):62-4. PubMed ID: 4478943
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cystine aminopeptidase and oxytocin in the plasma of pregnant patients with premature labor].
    Günther R; Landgraf R; Köppe I
    Zentralbl Gynakol; 1985; 107(19):1178-85. PubMed ID: 4072476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of post-gestational hypothalamosis on the relations between oxytocinasemia and the type of feto-maternal immunization].
    Klimek R; Turowski G; Zdebski Z
    Ginekol Pol; 1974 Aug; 45(8):1009-13. PubMed ID: 4409383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum oxytocinase. Its determination during normal and pathological pregnancies].
    Guibaud S; Ruffin D; Dumont M
    J Gynecol Obstet Biol Reprod (Paris); 1972 Jun; 1(4):353-60. PubMed ID: 4563076
    [No Abstract]   [Full Text] [Related]  

  • 13. [Test of fetal tolerance to uterine contractions. Analysis of 210 tests].
    López García R; Avila Gamboa D; García Alonso A; Lozano de la Garza JG; Shor Pinsker V; Karchmer S
    Ginecol Obstet Mex; 1978 Mar; 43(257):201-10. PubMed ID: 658736
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cystine aminopeptidase (oxytocinase) in physiological and pathological pregnancy and its value in establishing prognosis of the fetus at risk (author's transl)].
    Simko J
    Bratisl Lek Listy; 1981 Dec; 76(6):649-55. PubMed ID: 7317801
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of cystyl aminopeptidase analysis in clinical tests].
    Kosaka A; Nakane K
    Nihon Rinsho; 1989 Dec; 48 Suppl():295-7. PubMed ID: 2621888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Continual fetal monitoring].
    Krause W; Volkmer H; Ipach K; Nöschel H; Günther M; Zenner I; Seewald HJ
    Zentralbl Gynakol; 1973 Aug; 95(32):1111-21. PubMed ID: 4586915
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fetal rhythm disorders during pregnancy and birth].
    Baumgarten K; Fröhlich H
    Z Geburtshilfe Perinatol; 1972 Aug; 176(4):249-65. PubMed ID: 4562776
    [No Abstract]   [Full Text] [Related]  

  • 18. Value of umbilical blood acid-base studies in fetal assessment.
    Gordon A; Johnson JW
    J Reprod Med; 1985 Apr; 30(4):329-36. PubMed ID: 4009549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fetal heart rhythm variations and state of the infant at birth].
    Melchior J; Bernard N; Pinardeau M
    J Gynecol Obstet Biol Reprod (Paris); 1972 Sep; 1(6):595. PubMed ID: 4675212
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic value of oxytocinasemia in prolonged pregnancy].
    Zarzycki H; Szymańska E
    Ginekol Pol; 1970 Nov; 41(11):1207-13. PubMed ID: 5487526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.